ATOSSA THERAPEUTICS, INC. - 8-K Filing
Atossa Therapeutics declared stapled contingent value rights (CVRs) tied to potential FDA priority review voucher proceeds (Items: 1.01 Entry into a Material Definitive Agreement, 3.03 Material Modification to Rights of Security Holders, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $ATOS